Table 5 Common potentially inappropriate medications with renal contraindications, dose adjustments, or precautions for the study population
Medications that are both PIM and RIM | Group of drug | DCI | Patients n (%) |
|---|---|---|---|
Central hypertensive drug | Rilmenidine | 92 (16.5) | |
Central hypertensive drug | Moxonidine | 9 (1.6) | |
Central hypertensive drug | Clonidine | 6 (1.1) | |
Central hypertensive drug | Methyldopa | 1 (0.2) | |
Long-term benzodiazepine | Lorazepam | 31 (5,6) | |
Long-term benzodiazepine | Bromazepam | 17 (3.1) | |
Long-term benzodiazepine | Clonazepam | 14 (2.5) | |
Long-term benzodiazepine | Clorazepate | 8 (1.4) | |
Long-term benzodiazepine | Lormetazepam | 6 (1.1) | |
Long-term benzodiazepine | Clobazam | 5 (0.9) | |
Long-term benzodiazepine | Prazepam | 3 (0.5) | |
Long-term benzodiazepine | Clotiazepam | 2 (0.4) | |
Long-term benzodiazepine | Loprazolam | 2 (0.4) | |
Long-term benzodiazepine | Ethylloflazepate | 1 (0.2) | |
Anticholinergic drug | Hydroxyzine | 27 (4.9) | |
Anticholinergic drug | Mirtazapine | 9 (1.6) | |
Anticholinergic drug | Amitriptyline | 4 (0.7) | |
Anticholinergic drug | Dexchlorpheniramine | 3 (0.5) | |
Anticholinergic drug | Alimemazine | 2 (0.4) | |
Anticholinergic drug | Ropinirole | 1 (0.2) | |
Vasodilator | Buflomedil | 20 (3.6) | |
Vasodilator | Pentoxifylline | 3 (0.5) | |
Other | Digoxin | 10 (1.8) | |
Other | Opium+Cafeine+paracetamol | 5 (0.9) | |
Other | Baclofen | 1 (0.2) | |
Other | Nitrofurantoin | 1 (0.2) |